MCID: ATR005
MIFTS: 49

Atrophic Gastritis

Categories: Gastrointestinal diseases, Rare diseases

Aliases & Classifications for Atrophic Gastritis

MalaCards integrated aliases for Atrophic Gastritis:

Name: Atrophic Gastritis 12 15 17
Gastritis, Atrophic 45 74
Gastritis Atrophic 56
Gastric Atrophy 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8929
ICD9CM 36 535.1
MeSH 45 D005757
NCIt 51 C7405
SNOMED-CT 69 84568007
ICD10 34 K29.4
UMLS 74 C0017154

Summaries for Atrophic Gastritis

MalaCards based summary : Atrophic Gastritis, also known as gastritis, atrophic, is related to autoimmune atrophic gastritis and helicobacter pylori infection, and has symptoms including dyspepsia An important gene associated with Atrophic Gastritis is CHGA (Chromogranin A), and among its related pathways/superpathways are Spinal Cord Injury and Interleukin-4 and 13 signaling. The drugs Hydroxocobalamin and Methylcobalamin have been mentioned in the context of this disorder. Affiliated tissues include testes, thyroid and t cells, and related phenotypes are Increased TP53 mRNA expression and mortality/aging

Wikipedia : 77 Atrophic gastritis (also known as type A or type B gastritis) is a process of chronic inflammation of... more...

Related Diseases for Atrophic Gastritis

Diseases in the Atrophic Gastritis family:

Autoimmune Atrophic Gastritis

Diseases related to Atrophic Gastritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 157)
# Related Disease Score Top Affiliating Genes
1 autoimmune atrophic gastritis 34.6 CHGA GAST
2 helicobacter pylori infection 31.4 CXCL8 GAST IL1B S100A8
3 peptic esophagitis 30.9 CXCL8 IL1B
4 gastric ulcer 30.9 CXCL8 GAST IL1B IL1RN
5 zollinger-ellison syndrome 30.5 CHGA GAST SST
6 gastric cancer 30.4 CDX2 GAST IL1B IL1RN S100A8 TP53
7 gastrinoma 30.4 CHGA GAST SST
8 neuroendocrine tumor 30.4 CHGA GAST SST
9 esophagitis 30.3 CXCL8 IL1B TP53
10 duodenal gastrinoma 30.3 CHGA GAST SST
11 gastric neuroendocrine neoplasm 30.1 CHGA GAST SST
12 duodenogastric reflux 30.1 GAST SST
13 peptic ulcer disease 30.0 CXCL8 GAST GHRL IL1B IL1RN S100A8
14 duodenal ulcer 30.0 CXCL8 GAST IL1B IL1RN S100A8 SST
15 dyspepsia 29.8 CXCL8 GHRL PGC SST
16 gastritis 29.7 ADH7 CDX2 CHGA CXCL8 GAST GHRL
17 gastroesophageal reflux 29.5 CDX2 CXCL8 GAST GHRL IL1B TP53
18 gastric adenocarcinoma 28.4 CDX2 CHGA CXCL8 GAST IL1B IL1RN
19 pernicious anemia 11.7
20 megaloblastic anemia 1 11.1
21 adenocarcinoma 10.4
22 iron metabolism disease 10.4
23 exudative glomerulonephritis 10.4 CXCL8 IL1B
24 recurrent corneal erosion 10.4 CXCL8 IL1B
25 bagassosis 10.4 CXCL8 IL1B
26 goblet cell carcinoid 10.4 CHGA GAST
27 vulvar vestibulitis syndrome 10.3 IL1B IL1RN
28 vaginal benign neoplasm 10.3 CDX2 CHGA
29 vaginal adenoma 10.3 CDX2 CHGA
30 vaginal tubulovillous adenoma 10.3 CDX2 CHGA
31 pouchitis 10.3 CXCL8 IL1RN
32 vitamin b12 deficiency 10.3
33 schnitzler syndrome 10.3 IL1B IL1RN
34 funisitis 10.3 CXCL8 IL1B
35 haemophilus influenzae 10.3 CXCL8 IL1B
36 aseptic meningitis 10.3 CXCL8 IL1B IL1RN
37 opisthorchiasis 10.3 CXCL8 IL1B
38 silicosis 10.3 CXCL8 IL1B IL1RN
39 aggressive periodontitis 10.3 CXCL8 IL1B IL1RN
40 chorioamnionitis 10.3 CXCL8 IL1B IL1RN
41 osteomyelitis 10.2 CXCL8 IL1B IL1RN
42 bone inflammation disease 10.2 CXCL8 IL1B IL1RN
43 pancreatic cancer 10.2
44 deficiency anemia 10.2
45 synovitis 10.2 CXCL8 IL1B IL1RN
46 proteasome-associated autoinflammatory syndrome 1 10.2 CXCL8 IL1B IL1RN
47 non-functioning pancreatic endocrine tumor 10.2 CHGA GAST GHRL
48 cerebral artery occlusion 10.2 IL1B ODC1
49 postcholecystectomy syndrome 10.2 GAST SST
50 periodontal disease 10.2 CXCL8 IL1B IL1RN

Comorbidity relations with Atrophic Gastritis via Phenotypic Disease Network (PDN): (show all 18)


Active Peptic Ulcer Disease Acute Cystitis
Acute Pancreatitis Anxiety
Bronchitis Chronic Myocardial Ischemia
Deficiency Anemia Duodenitis
Dysthymic Disorder Esophagitis
Heart Disease Hypertension, Essential
Intermediate Coronary Syndrome Iron Deficiency Anemia
Irritable Bowel Syndrome Ischemic Heart Disease
Paralytic Ileus Protein-Energy Malnutrition

Graphical network of the top 20 diseases related to Atrophic Gastritis:



Diseases related to Atrophic Gastritis

Symptoms & Phenotypes for Atrophic Gastritis

UMLS symptoms related to Atrophic Gastritis:


dyspepsia

GenomeRNAi Phenotypes related to Atrophic Gastritis according to GeneCards Suite gene sharing:

27
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased TP53 mRNA expression GR00389-S-6 8.62 ERCC6 TP53

MGI Mouse Phenotypes related to Atrophic Gastritis:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 mortality/aging MP:0010768 9.36 ADH7 CDX2 CHGA ERCC6 GAST IL1B

Drugs & Therapeutics for Atrophic Gastritis

Drugs for Atrophic Gastritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 107)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Hydroxocobalamin Approved Phase 4,Not Applicable 13422-51-0 15589840 11953898
2
Methylcobalamin Approved, Experimental, Investigational Phase 4 13422-55-4
3
Amphotericin B Approved, Investigational Phase 4 1397-89-3 5280965 14956
4
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
5
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 26787-78-0 33613
6
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
7
Metronidazole Approved Phase 4,Phase 3 443-48-1 4173
8
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
9
Esomeprazole Approved, Investigational Phase 4 161796-78-7, 161973-10-0, 119141-88-7 9568614 4594
10
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
11
Polyestradiol phosphate Approved Phase 4 28014-46-2
12
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
13
Clarithromycin Approved Phase 4,Phase 3,Phase 2,Not Applicable 81103-11-9 84029
14
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 59-30-3 6037
15
Cyanocobalamin Approved, Nutraceutical Phase 4,Not Applicable 68-19-9 44176380
16
Cobalamin Experimental Phase 4,Not Applicable 13408-78-1 6857388
17 Vitamins Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1
18 Vitamin B Complex Phase 4,Phase 1,Phase 2,Not Applicable
19 Trace Elements Phase 4,Phase 1,Phase 2,Not Applicable,Early Phase 1
20 Vitamin B12 Phase 4,Not Applicable
21 Hematinics Phase 4,Phase 1,Phase 2,Not Applicable
22 Folate Phase 4,Phase 1,Phase 2,Not Applicable
23 Nutrients Phase 4,Phase 1,Phase 2,Not Applicable,Early Phase 1
24 Micronutrients Phase 4,Phase 1,Phase 2,Not Applicable,Early Phase 1
25 Vitamin B 12 Phase 4,Not Applicable
26 Vitamin B9 Phase 4,Phase 1,Phase 2,Not Applicable
27 Anti-Ulcer Agents Phase 4,Phase 3,Not Applicable
28 Gastrointestinal Agents Phase 4,Phase 3,Not Applicable
29 Antacids Phase 4,Phase 3,Not Applicable
30 Proton Pump Inhibitors Phase 4,Phase 3
31 Liposomal amphotericin B Phase 4
32 Topoisomerase Inhibitors Phase 4
33 Contraceptives, Oral, Combined Phase 4
34 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
35 Contraceptive Agents Phase 4
36 Contraceptives, Oral Phase 4
37 Antiparasitic Agents Phase 4,Phase 3,Phase 2
38 Estradiol 3-benzoate Phase 4
39 Anti-Infective Agents Phase 4,Phase 3,Phase 2
40 Estradiol 17 beta-cypionate Phase 4
41 Antiprotozoal Agents Phase 4,Phase 3,Phase 2
42
Bismuth Phase 4 7440-69-9 105143 16682734
43 Norgestimate, ethinyl estradiol drug combination Phase 4
44 Geranylgeranylacetone Phase 4
45
Omeprazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Not Applicable 73590-58-6 4594
46
Guaifenesin Approved, Investigational, Vet_approved Phase 3 93-14-1 3516
47
Tocopherol Approved, Investigational Phase 3 1406-66-2 14986
48
Selenium Approved, Investigational, Vet_approved Phase 3 7782-49-2
49
Vitamin E Approved, Nutraceutical, Vet_approved Phase 3 59-02-9 14985
50
Vitamin C Approved, Nutraceutical Phase 3 50-81-7 54670067 5785

Interventional clinical trials:

(show top 50) (show all 62)
# Name Status NCT ID Phase Drugs
1 To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG) Completed NCT01474044 Phase 4 Gastropylor Complex Capsules
2 Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy Completed NCT01792700 Phase 4 esomeprazole;tripotassium dicitrate bismuthate;metronidazole;tetracycline;moxifloxacin;amoxicillin
3 A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab. Completed NCT01817556 Phase 4 Stillen Tab.;Mucosta Tab.
4 Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients Completed NCT01119768 Phase 4 Esomeprazole;Esomeprazole
5 Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer Completed NCT01190657 Phase 4 Selbex;Selbex
6 Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality Recruiting NCT02047994 Phase 4 Triple therapy
7 Intragastric pH and Bismuth Effect for H. Pylori Eradication Not yet recruiting NCT02894892 Phase 4 (A)Bismuth;(B)Bismuth;(C)Bismuth;(D)Esomeprazole and Bismuth;(E)Esomeprazole and Bismuth;(F)Esomeprazole and Bismuth
8 The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study Not yet recruiting NCT02933229 Phase 4 H. pylori eradication
9 A Study to Evaluate the Efficacy and Safety of DA-5204 Unknown status NCT02282670 Phase 3 DA-5204;Stillen tab.
10 A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034 Unknown status NCT01813812 Phase 3 DA-6034;Rebamipide 300mg
11 Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia Completed NCT00719420 Phase 3 Clarithromycin, Metronidazole, Amoxicillin (+Omeprazole);Clarithromycin, Amoxicillin, Omeprazole
12 A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province Completed NCT00339768 Phase 3 Amoxicillin/omeprazole
13 Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis Completed NCT00996788 Phase 3 Rebamipide
14 Gastric Preparation of Magnetic-controlled Capsule Endoscopy Unknown status NCT02846155 Phase 2 simethicone;simethicone combined with pronase
15 L-cysteine Prevents Stomach Exposure to Carcinogenic Acetaldehyde Completed NCT02524262 Phase 2
16 Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer Completed NCT01002443 Phase 2 Helicobacter pylori eradication;placebo
17 Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia Recruiting NCT02782949 Phase 2 Curcumin
18 Chemoprevention of Gastric Carcinogenesis Recruiting NCT02794428 Phase 2 Eflornithine
19 YF476 and Type I Gastric Carcinoids Active, not recruiting NCT01339169 Phase 2 YF476
20 Jianpi Huoxue Recipe in Treating Gastric Premalignant Lesion Not yet recruiting NCT03823248 Phase 1, Phase 2 MoLuoDan;Sanchi powder;Folic Acid Tablet;MoLuoDan simulation;Sanchi powder simulation;Folic Acid Tablet simulation
21 YF476 and Type I Gastric Carcinoids (Norway) Terminated NCT01444014 Phase 2 YF476
22 Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study Unknown status NCT02675010 Not Applicable
23 Difference of Gastric Microbiota in the Process of Correa's Model. Unknown status NCT02833363
24 HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome Unknown status NCT01931293 Not Applicable
25 Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer Risk Unknown status NCT02624271 Not Applicable
26 Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy Unknown status NCT02126722
27 Immunologic Factors in Reflux Esophagitis and Barrett’s Esophagus Unknown status NCT00155805
28 Oxidative Stress in Intestinal Metaplasia and Metabolic Syndrome Unknown status NCT02695186
29 Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway Unknown status NCT00498134 Not Applicable Triple therapy for H. pylori infection;Cox-2 inhibitor
30 Detection of Methylated Reprimo in Plasma for Asymptomatic Gastric Cancer Unknown status NCT01774266
31 Grading Atrophic Gastritis by Confocal Laser Endomicroscopy Probe (p-CLE) Completed NCT02351154 Not Applicable
32 Long-term Follow-up Prognosis of Atrophic Gastritis After 3 Years Completed NCT01824953
33 Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy Completed NCT02724280 Not Applicable
34 New Technology to Differentiate Normal Gastric Mucosa From Helicobacter Pylori Associated Gastritis and Gastric Atrophy Completed NCT02597517
35 OLGA Stage is More Appropriate in Predicting Early Gastric Cancer Completed NCT02562976
36 Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis Completed NCT00920712 Not Applicable Weiqi decotion
37 Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori) Completed NCT00212225
38 A Randomized Study Comparing Autofluorescence Imaging(AFI) Followed by Narrow Band Imaging(NBI) With Videoendoscopy for the Detection of High Risk Lesions of Stomach Completed NCT01132534
39 New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy Completed NCT01896310
40 Optimal Site for Rapid Urease Test in the Stomach Completed NCT02945137
41 Performances of a Fast Test for the Detection of Helicobacter Pylori Antigens in Child Stool Completed NCT03324763
42 Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer Completed NCT01813994 Not Applicable Arm1: Statin;Arm2: Placebo
43 Volatile Markers in Digestive Cancer Completed NCT02332213
44 Effect of Chicken Egg Antibody (IgY) on Patients With Chronic Gastritis Completed NCT02721355 Not Applicable
45 Helicobacter Pylori and Proton Pump Inhibitor Completed NCT02449941 PPI (proton pump inhibitor)
46 Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients Recruiting NCT02691637
47 Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea Recruiting NCT02184910 pepsinogen and gastrin
48 Syndrome Patterns for Chronic Atrophic Gastritis Malignant Transformation Recruiting NCT03314038
49 Gastropanel for Gastric Atrophy and Cancer Risk Assessment Recruiting NCT02114411
50 Gastric Cancer Screening Quality Improvement System Establishment Recruiting NCT02457624

Search NIH Clinical Center for Atrophic Gastritis

Cochrane evidence based reviews: gastritis, atrophic

Genetic Tests for Atrophic Gastritis

Anatomical Context for Atrophic Gastritis

MalaCards organs/tissues related to Atrophic Gastritis:

42
Testes, Thyroid, T Cells, Liver, Bone, Spleen, Pancreas

Publications for Atrophic Gastritis

Articles related to Atrophic Gastritis:

(show top 50) (show all 769)
# Title Authors Year
1
Atrophic Gastritis as a Risk Factor for Bone Loss in Premenopausal Women in Their 40s: A Retrospective Cohort Study. ( 30191283 )
2019
2
Grading of Atrophic Gastritis is Useful for Risk Stratification in Endoscopic Screening for Gastric Cancer. ( 30315306 )
2019
3
Nuclear magnetic resonance-based metabolomics approach to evaluate preventive and therapeutic effects of Gastrodia elata Blume on chronic atrophic gastritis. ( 30391812 )
2019
4
Gastric Neuroendocrine Tumor and Duodenal Gastrinoma With Chronic Autoimmune Atrophic Gastritis. ( 30531243 )
2019
5
The incidence of neoplasia in patients with autoimmune metaplastic atrophic gastritis: a renewed call for surveillance. ( 30598594 )
2019
6
The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective. ( 30639639 )
2019
7
Diagnostic performance of serum pepsinogen assay for the prediction of atrophic gastritis and gastric neoplasms: Protocol for a systematic review and meta-analysis. ( 30681610 )
2019
8
Prevalence and determinants of serological evidence of atrophic gastritis among Arab and Jewish residents of Jerusalem: a cross-sectional study. ( 30700483 )
2019
9
Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs. ( 30736753 )
2019
10
Notoginsenoside R1 (NGR1) Attenuates Chronic Atrophic Gastritis in Rats. ( 30757999 )
2019
11
Correction: Grading of Atrophic Gastritis is Useful for Risk Stratification in Endoscopic Screening for Gastric Cancer. ( 30844907 )
2019
12
Effect of Citric Acid on Accuracy of 13C-Urea Breath Test after Helicobacter pylori Eradication Therapy in a Region with a High Prevalence of Atrophic Gastritis. ( 30970440 )
2019
13
Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study. ( 30988344 )
2019
14
Network pharmacology based investigation into the effect and mechanism of Modified Sijunzi Decoction against the subtypes of chronic atrophic gastritis. ( 30991106 )
2019
15
Do subjects with mild or moderate atrophic gastritis or intestinal metaplasia confined to the antrum benefit from gastric cancer surveillance? ( 31030192 )
2019
16
Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer. ( 31083432 )
2019
17
Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. ( 31083485 )
2019
18
Associations among Gastric Juice pH, Atrophic Gastritis, Intestinal Metaplasia and Helicobacter pylori Infection. ( 28918609 )
2018
19
The relationship of interpersonal sensitivity and depression among patients with chronic atrophic gastritis: The mediating role of coping styles. ( 29052273 )
2018
20
Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years. ( 29193217 )
2018
21
Symptomatic Non-acidic Reflux in a Patient With Chronic Autoimmune Atrophic Gastritis Successfully Treated With Anti-reflux Surgery. ( 29291616 )
2018
22
Psychological distress in patients with chronic atrophic gastritis: the risk factors, protection factors, and cumulative effect. ( 29353492 )
2018
23
Impact of SNP-SNP interactions of DNA repair gene ERCC5 and metabolic gene GSTP1 on gastric cancer/atrophic gastritis risk in a Chinese population. ( 29434449 )
2018
24
Infertility and recurrent miscarriage in a patient with autoimmune atrophic gastritis. ( 29524079 )
2018
25
Unusual association between erythema nodosum and autoimmune atrophic gastritis. ( 29545439 )
2018
26
Hierarchical and Complex System Entropy Clustering Analysis Based Validation for Traditional Chinese Medicine Syndrome Patterns of Chronic Atrophic Gastritis. ( 29565647 )
2018
27
Helicobacter pylori Eradication Therapy Ameliorates Latent Digestive Symptoms in Chronic Atrophic Gastritis. ( 29587295 )
2018
28
Correlation between serum vitamin B12 level and peripheral neuropathy in atrophic gastritis. ( 29599609 )
2018
29
Training Effect on the Inter-observer Agreement in Endoscopic Diagnosis and Grading of Atrophic Gastritis according to Level of Endoscopic Experience. ( 29629520 )
2018
30
Multiplex serology of Helicobacter pylori antigens in detection of current infection and atrophic gastritis - A simple and cost-efficient method. ( 29665437 )
2018
31
Infection of Helicobacter pylori and Atrophic Gastritis Influence Lactobacillus in Gut Microbiota in a Japanese Population. ( 29681906 )
2018
32
Accuracy of Endoscopic Diagnosis for Mild Atrophic Gastritis Infected with Helicobacter pylori. ( 29695148 )
2018
33
Extranodal Rosai-Dorfman Disease With Mucosal Involvement of the Stomach in a Background of Autoimmune Atrophic Gastritis. ( 29720012 )
2018
34
Low PG I/II ratio as a marker of atrophic gastritis: Association with nutritional and metabolic status in healthy people. ( 29768385 )
2018
35
Material basis research for Huangqi Jianzhong Tang against chronic atrophic gastritis rats through integration of urinary metabonomics and SystemsDock. ( 29777900 )
2018
36
Identification of N- and O-linked glycans recognized by AAL in saliva of patients with atrophic gastritis and gastric cancer. ( 29865036 )
2018
37
Treatment of Helicobacter pylori infection in atrophic gastritis. ( 29904244 )
2018
38
A case of Metaplastic atrophic gastritis in immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) syndrome. ( 29907148 )
2018
39
Occurrence of gastric cancer in patients with atrophic gastritis during long-term follow-up. ( 29911441 )
2018
40
Polymorphism rs7521584 in miR‑429 is associated with the severity of atrophic gastritis in patients with Helicobacter pylori infection. ( 29956763 )
2018
41
Accuracy of Endoscopic Diagnosis of Mild Atrophic Gastritis with Helicobacter pylori Infection. ( 30001615 )
2018
42
Mid- and Deep-Zone Gastritis: A Histologic Pattern Associated With Autoimmune Disease but Distinct From Autoimmune Atrophic Gastritis. ( 30032289 )
2018
43
Exploring the potential pharmacodynamic material basis and pharmacologic mechanism of the Fufang-Xialian-Capsule in chronic atrophic gastritis by network pharmacology approach based on the components absorbed into the blood. ( 30110485 )
2018
44
SNP interactions of PGC with its neighbor lncRNAs enhance the susceptibility to gastric cancer/atrophic gastritis and influence the expression of involved molecules. ( 30155999 )
2018
45
Occurrence and predictors of metaplastic atrophic gastritis in a nation-wide consecutive endoscopic population presenting with upper gastrointestinal symptoms. ( 30161028 )
2018
46
Optical biopsy strategy for the assessment of atrophic gastritis, intestinal metaplasia, and dysplasia. ( 30173255 )
2018
47
Association of IL10 gene promoter polymorphisms with risks of gastric cancer and atrophic gastritis. ( 30205739 )
2018
48
Potential role of chromatin remodeling factor genes in atrophic gastritis/gastric cancer risk. ( 30249557 )
2018
49
Risk factors for atrophic gastritis in the Japanese young and middle-aged: a study using double-contrast upper gastrointestinal barium X-ray radiography. ( 30259311 )
2018
50
Difference of Liver and Kidney Metabolic Profiling in Chronic Atrophic Gastritis Rats between Acupuncture and Moxibustion Treatment. ( 30310411 )
2018

Variations for Atrophic Gastritis

Expression for Atrophic Gastritis

Search GEO for disease gene expression data for Atrophic Gastritis.

Pathways for Atrophic Gastritis

Pathways related to Atrophic Gastritis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.58 CXCL8 IL1B TP53
2 11.49 CXCL8 IL1B TP53
3 11.36 CXCL8 IL1B TP53
4 11.14 CXCL8 IL1B IL1RN SST
5 10.82 CXCL8 IL1B IL1RN

GO Terms for Atrophic Gastritis

Cellular components related to Atrophic Gastritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.61 CHGA CXCL8 GAST GHRL IL1B IL1RN
2 extracellular region GO:0005576 9.36 CHGA CXCL8 GAST GHRL IL1B IL1RN
3 multivesicular body lumen GO:0097486 9.16 PGA3 PGA5

Biological processes related to Atrophic Gastritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.76 CXCL8 IL1B IL1RN S100A8
2 cytokine-mediated signaling pathway GO:0019221 9.67 CXCL8 IL1B IL1RN TP53
3 protein catabolic process GO:0030163 9.5 PGA3 PGA5 PGC
4 neutrophil chemotaxis GO:0030593 9.46 CXCL8 IL1B IL1RN S100A8
5 positive regulation of protein export from nucleus GO:0046827 9.43 IL1B TP53
6 regulation of signaling receptor activity GO:0010469 9.43 CXCL8 GAST GHRL IL1B IL1RN SST
7 response to ethanol GO:0045471 9.4 ADH7 S100A8
8 response to gamma radiation GO:0010332 9.26 ERCC6 TP53
9 digestion GO:0007586 8.92 PGA3 PGA5 PGC SST

Molecular functions related to Atrophic Gastritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 9.43 GAST GHRL SST
2 interleukin-1 receptor binding GO:0005149 9.16 IL1B IL1RN
3 protein tyrosine kinase activator activity GO:0030296 8.96 ERCC6 GHRL
4 aspartic-type endopeptidase activity GO:0004190 8.8 PGA3 PGA5 PGC

Sources for Atrophic Gastritis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....